Literature DB >> 12353927

Nafamostat mesilate attenuates radical formation in the rat lung infused with endotoxin.

Yoshihiro Minamiya1, Satoshi Saito, Masakatsu Nakamura, Kasumi Tozawa, Hajime Saito, Ikuo Matsuzaki, Jun-ichi Ogawa.   

Abstract

We previously reported direct evidence of respiratory bursting by neutrophils in the pulmonary circulation of endotoxin-infused rats. To evaluate the effect of the protease inhibitor nafamostat mesilate (NM) on leukocyte-mediated radical formation in the pulmonary circulation of rats infused with endotoxin, we observed and measured the number of sticking leukocytes and quantified radical production in the pulmonary circulation of endotoxin-infused rats by means of a fluorescent imaging technique. Plasma C3a (desArg) was also measured using an enzyme-linked immunosorbent assay. Three groups (n = 5) of rats were infused with 4.5 mg/kg/h endotoxin (Et group), 50 microg/kg/h NM + endotoxin (NM group), or physiological saline (Ct group) for 2 h. The number of the leukocytes adhering within pulmonary capillaries, oxygen radical production in the rat pulmonary circulation, and plasma C3a (desArg) were all lower in the NM group than in the Et group. The leukocytes producing oxygen radicals were confirmed to be neutrophils by electron microscopic analysis of cerium deposition. We conclude that NM attenuates plasma C3a formation, neutrophil adherence to pulmonary capillaries, and their production of oxygen radical in rats infused with endotoxin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12353927     DOI: 10.1097/00024382-200209000-00009

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  1 in total

1.  An anti-coagulation agent Futhan preferentially targets GABA(A) receptors in lungepithelia: implication in treating asthma.

Authors:  Xuanmao Chen; Minghua Li; Zhi-Gang Xiong; Beverley A Orser; John F Macdonald; Wei-Yang Lu
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-11-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.